Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 9-14

  Wu, Ming Shiang ^a   Wang, Hsiu Po ^a   Lin, Chun Che ^a   Sheu, Jin Chuan ^a   Shun, Chia Tung ^a   Lee, Wei Jei ^a   Lin, Jaw Town ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Gastric cancer; Genomic imprinting; H19; IGF2

Indexed keywords

SOMATOMEDIN B;

ARTICLE; GENE OVEREXPRESSION; GENOME IMPRINTING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ALLELES; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMPRINTING (PSYCHOLOGY); INSULIN-LIKE GROWTH FACTOR II; MALE; MUSCLE PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, NEOPLASM; RNA, UNTRANSLATED; STOMACH NEOPLASMS;

EID: 0030862361     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00279-6     Document Type: Article

References (31)

1. Tycko B. Genomic imprinting: mechanism and role in human pathology. Am. J. Pathol. 144:1994;431-443.
2. Zemel S., Bartolomei M.S., Tilghman S.M. Physical linkage of the mammalian imprinted gene H19 and insulin-like growth factor 2. Nat. Genet. 2:1992;61-65.
3. Dechiara T.M., Efstradiadis A., Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 345:1990;78-80.
4. Quinn K.A., Treston A.M., Unsworth E.J., Miller M.J., Vos M., Grimley C., Battey J., Mulshine J.L., Cuttita F. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271:1996;11477-11483.
5. Christofori G., Naik P., Hanahan D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumorigenesis. Nat. Genet. 10:1995;196-201.
6. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinberg A.P. Relaxation of imprinted gene in human cancer. Nature. 362:1993;747-749.
7. Zhan S., Shapiro D.N., Helman L.J. Activation of an imprinted allele of the insulin-like growth factor II gene imprinted in rhabdomyosarcoma. J. Clin. Invest. 94:1994;445-448.
8. Hashimoto K., Azuma C., Koyama M., Ohashi K., Kamiura S., Nobunaga T., Kimura T., Tokugawa Y., Kanai T., Saji F. Loss of imprinting in choriocarcinoma. Nat. Genet. 9:1995;109-110.
9. Suzuki H., Ueda R., Takahashi T., Takahashi T. Altered imprinting in lung cancer. Nat. Genet. 6:1994;332-333.
10. Rainier S., Dobry C.J., Feinberg A.P. Loss of imprinting in hepatoblastoma. Cancer Res. 55:1995;1836-1838.
11. Vu T., Yballe C., Boonyanit S., Hoffman A.R. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyoma and loss of imprinting in leiomyosarcoma. J. Clin. Endocrinol. Metab. 80:1995;1670-1676.
12. Douc-Rasy S., Barrois M., Fogel S., Ahomadegbe J.C., Stehelin D., Coll J., Riou G. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinoma: uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene. 12:1996;423-430.
13. Jarrard D.F., Bussemakers M., Bova G.S., Isaacs W.B. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Clin. Cancer Res. 1:1995;1471-1478.
14. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19 RNA. Nature. 365:1993;764-767.
15. Steenman M.J.C., Rainier S., Dobry C.J., Grundy P., Horon I.L., Feinberg A.P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat. Genet. 7:1994;433-439.
16. Tahara E. Genetic alterations in human gastrointestinal cancers: the application to molecular diagnosis. Cancer. 75:1995;1410-1417.
17. Whitehead R.H., Novak U., Thomas R.J., Lukeis R.E., Walker F.E., Jones J. A new gastric carcinoma cell line (LIM 1839) derived from a young Caucasian male. Int. J. Cancer. 44:1989;1100-1103.
18. Yokozaki H., Kuniyasu H., Yasui W., Tahara E. Genetic characteristics of scirrhous gastric carcinoma. Jpn. J. Cancer Chemother. 21:1994;2371-2377.
19. Rodriguez E., Rao P.H., Ladanyi M., Altorki N., Albino A.P., Kelsen D.P., Jhanwar S.C., Chaganti R.S.K. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinoma. Cancer Res. 50:1990;6410-6416.
20. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G.N., Hirohashi S., Croce C.M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56:1996;268-272.
21. Lauren T. The two histologic main types of gastric carcinoma. Acta Pathol. Microbiol. Scand. 64:1965;34-49.
22. Lin J.T., Wu M.S., Shun C.T., Lee W.J., Wang J.T., Wang T.H., Sheu J.C. Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages. Eur. J. Cancer. 31A:1995;1879-1882.
23. Tadokoro K.H., Fujii H., Inoue T., Yamada M. Polymerase chain reaction for detection of Apa I polymorphism at the insulin-like growth factor II (IGFII) gene. Nucleic Acids Res. 19:1991;6967.
24. Zhang Y., Tycko B. Monoallelic expression of the human H19 gene. Nat. Genet. 1:1992;40-44.
25. Harrington E.A., Bennett M.E., Fanidi A., Evan G.I. C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO. J. 13:1994;3286-3295.
26. Rainier S., Feinberg A.P. Genomic imprinting, DNA methylation and cancer. J. Natl. Cancer Inst. 86:1994;753-759.
27. Ellis M.J., Singer C., Hornby A., Rasmussen A., Cullen K.J. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res. Treat. 31:1994;249-261.
28. Singer C., Rasmussen A., Smith H.S., Lippman M.E., Lynch H.T., Cullen K.J. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res. 55:1995;2448-2454.
29. Li X., Adam G., Cui H., Sandstedt B., Ohlsson R., Ekstrom T.J. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene. 11:1995;221-229.
30. Uyeno S., Aoki Y., Nata M., Sagisaka K., Kayama T., Yoshimoto T., Ono T. IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res. 56:1996;5356-5359.
31. Hibi K., Nakamura H., Hirai A., Fujikake Y., Kasai Y., Akiyama S., Ito K., Takagi H. Loss of H19 imprinting in esophageal cancer. Cancer Res. 56:1996;480-482.